There are fewer antifungal, anti protozoan, and antihelminthic drugs compared to antibacterial drugs because these cells can be similar to human cells and therefore they can not achieve selective toxicity.
<h3>What is drug selective toxicity?</h3>
The expression 'drug selective toxicity' makes reference to the ability of a specific medication to discriminate between cells of different organisms (in this case human cells and other types of eukaryotic cells).
Drug selective toxicity is a fundamental issue during drug discovery and drug development.
In conclusion, there are fewer antifungal, anti protozoan, and antihelminthic drugs compared to antibacterial drugs because these cells can be similar to human cells and therefore they can not achieve selective toxicity.
Learn more about drug selectivity here:
brainly.com/question/13700694
#SPJ1
Catheters are usually used to drain the bladder and are used on individual who have urinary incontinence (leaking urine or being unable to control when you urinate) Urinary retention (being unable to empty your bladder when you need to)
Answer:
The best answer to the question: Development of the testes in the embryo is due to:___, would be, C: Presence of a single Y chromosome.
Explanation:
The subject of sexual differentiation into male, or female, during the prenatal, and especially embryonic stage, is still a matter of study and research. Although many of the processes are widely accepted and understood, studies show that there may be other factors involved in sexual differentiation. However, what has been known so far is that in the embryonic stage, the presence of TDF (testis-determining factor) is crucial to this determination. TDF is a product of the presence of the Y chromosome in the gene known as SRY. It has been seen that when this protein product is not presence, there will be no growth of the necessary parts for male differentiation from a female.
Answer:
she needs to know that she must take iron even if she is not anemic
The correct answer is D) An apparently longer survival time among persons identified during a screening program because they were identified at an earlier stage of their disease
Explanation:
In medicine, screening is a method to diagnose diseases even if the person has no symptoms; due to this, screening is related to earlier detection of diseases than traditional diagnosis based on symptoms. Early diagnosis does not imply longer survival time, but it can lead to doctors or individuals to perceive the survival time was longer, this phenomenon is known as lead-time bias.
For example, a person diagnosed with cancer at an early stage when he is 45 years old, dies at 50 years old, this means his survival time was 5 years. If the same person is diagnosed at 48 years based on symptoms and he dies at 50 it seems the survival time is less (2 years); however, this is biased as the diagnosis did not change the effect of the disease. According to this, lead-time bias can be described as "an apparently longer survival time among persons identified during a screening program because they were identified at an earlier stage of their disease".
